rhein has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Huang, SR; Liu, H; Sun, J; Zhang, TA; Zhang, WY | 1 |
| Chen, A; Cheng, X; Huang, Y; Sun, J; Wang, X; Zhang, G; Zhao, Q; Zhao, Y; Zhu, Y | 1 |
2 other study(ies) available for rhein and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway.
Topics: Animals; Anthraquinones; Brain Ischemia; Ferroptosis; Glucose; Infarction, Middle Cerebral Artery; Ischemic Stroke; Molecular Docking Simulation; Neuroprotective Agents; NF-E2-Related Factor 2; Oxygen; Rats; Reactive Oxygen Species; Reperfusion Injury | 2023 |
Rhein protects against cerebral ischemic‑/reperfusion‑induced oxidative stress and apoptosis in rats.
Topics: Animals; Anthraquinones; Antioxidants; Apoptosis; Brain; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Oxidative Stress; Rats, Sprague-Dawley | 2018 |